Trial Profile
Double-blind, randomized, placebo-controlled cross-over dose finding study of two doses of lorediplon in adult patients with insomnia disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2016
Price :
$35
*
At a glance
- Drugs Lorediplon (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Ferrer
- 14 Dec 2016 Status changed from recruiting to completed.
- 12 Feb 2014 New trial record